Name
142: Cardio-Kidney Proctection in CKD: The Role SGLT-2 Inhibitors, GLT 2Inhibitorsrenal, GLP-1 Agonists, on steroidal MRAs, and Future Directions
Date & Time
Saturday, April 25, 2026, 11:45 AM - 12:45 PM
Speakers
Description
This session will explore how two emerging pharmacologic classes—SGLT2 inhibitors and GLP-1 receptor agonists—are transforming care through synergistic cardio- and reno protective effects, before considering evolving guidelines, unmet needs, and next generation strategies in dialysis care.
Session Type
Concurrent
ANCC Contact Hours
1.0